Click it and Unblock the Notifications
Latest Updates
-
Horoscope for Today April 27, 2026 - Small Choices, Steady Progress, Calm Focus Today -
5 Bedroom Vastu Mistakes Couples Must Avoid To Prevent Arguments And Emotional Distance -
Chicken Tikka Recipe: Master the Smoky Grill Secret Method -
Skincare Hacks 101: Everyday Kitchen Ingredients That Support Skin Health When Used The Right Way -
Street Style Juicy Filling Chicken Momos Recipe -
Nita Ambani Stuns At TIME100: ‘Tribal Lore’ Jamdani Saree At Summit, Rare 101-Carat Diamond Necklace At Gala -
Raghu Rai, ‘Father Of Indian Photojournalism’ Who Captured A Nation’s Soul Passes Away At 83 -
May 2026 Horoscope: Pisces! Your Intuition Is Stronger Than Logic This Month, Let It Guide You -
Dhaba Style Rich Flavor Chicken Masala Recipe for Lunch -
Mohini Ekadashi 2026: 26th Or 27th April? Know The Correct Date, Significance, Puja Vidhi And Vrat Katha
COVID-19 Vaccination: Supply, Eligibility Will Decide Vax For Kids
The government will take a final decision on vaccinating children and adolescents against coronavirus on the basis of overall scientific rationale as well as the supply situation of vaccines available for those below 18 years, Covid task force chief V K Paul said on Sunday.
Paul also cautioned that even though infections were coming down and the second wave was subsiding, it would not be fair to say that the worst was over since many countries had seen more than two waves.
Currently, three vaccines - Covishield, Covaxin and Sputnik V - being administered in the country are only for those above 18. Zydus Cadila's needle-free vaccine ZyCoV-D is set to become the first that will be available in India for those between 12 and 18. It has received emergency use authorisation (EUA).
"We do know several countries have introduced vaccination for adolescents and children. We will make a final decision based on the overall scientific rationale and the supply situation of the child-licenced vaccines," Paul said.
An expert panel of India's central drug authority has recommended granting EUA to Bharat Biotech's Covaxin for children and adolescents in the 2-18 age group with certain conditions.
According to Paul, Covaxin is part of the adult vaccination programme and how to provide the vaccine, if at all for children, has to be also examined.
"A pragmatic decision can be taken (only) by balancing the supply and the potential eligibility," he said.
Paul said: "The preparation for incorporation of Zydus Cadila's vaccine into the vaccination programme is proceeding well, training is already being held."
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google